The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Normalization of Blood Pressure and Renal Vascular Resistance in SHR With a Membrane-Permeable Superoxide Dismutase Mimetic: Role of Nitric Oxide
Open accessAbstract
Abstract —Superoxide radical (O 2 − ) is increased in the vessel wall of spontaneously hypertensive rats (SHR) where its blockade potentiates endothelium-dependent vasodilation. The purpose of this study was to determine the role of O 2 − in the hypertension and renal vasoconstriction of SHR and its interaction with nitric oxide (NO). Baseline mean arterial pressure (MAP) and renal vascular resistance were markedly elevated in SHR (n=6) compared with Wistar-Kyoto rats (WKY; n=6) (145±4 versus 118±4 mm Hg, P <0.05, and 24±3 versus 17±1 mm Hg · mL −1 · min −1 , respectively; P <0.05). The stable membrane-permeable superoxide dismutase mimetic 4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl (tempol; 72 μmol/kg IV) normalized MAP (103±9 versus 96±6 mm Hg for SHR and WKY, respectively) and RVR (17±2 versus 15±1 mm Hg · mL −1 · min −1 ) of SHR. The MAP of SHR was more sensitive and responsive to graded infusions of tempol (0, 1.8, 18, 180, and 1800 μmol · kg −1 · h −1 IV) than that of WKY. To determine whether O 2 − increases MAP by inactivation of NO, its synthesis was blocked in SHR with N w -nitro- l -arginine methyl ester (L-NAME, 11 μmol · kg −1 · min −1 IV, n=6). Whereas tempol alone significantly reduced MAP by 32% (184±12 to 121±18 mm Hg, P <0.05, n=6), L-NAME infusion abolished the MAP response to tempol (187±8 to 186±4 mm Hg, n=5). In contrast, tempol did reduce MAP of SHR (188±7 to 161±7 mm Hg, P <0.05) where MAP was elevated by norepinephrine (31 nmol · kg −1 · min −1 IV, n=6). Finally, to determine the longer-term effect of O 2 − , tempol (1.5 mmol · kg −1 · d −1 IP) was given for 7 days. Tempol had no effect on MAP in WKY (96±1 to 97±1 mm Hg, n=7) but significantly decreased MAP in SHR (133±2 to 120±3 mm Hg, P <0.05, n=7). These data implicate O 2 − in the hypertension of SHR in vivo. The antihypertensive action of tempol depends on NO synthesis presumably because O 2 − inactivates NO and thus diminishes its vasodilatory actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Carew, T. E., Schwenke, D. C., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7725 · Cited by 1,035
Generation of superoxide by purified brain nitric oxide synthase
Pou, S., Pou, W. S., Bredt, D. S., Snyder, S. H., & Rosen, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35745-4 · Cited by 750
Does superoxide underlie the pathogenesis of hypertension?
Nakazono, K., Watanabe, N., Matsuno, K., Sasaki, J., Sato, T., & Inoue, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10045 · Cited by 747
Baylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.
Henson, P. M., & Johnston, R. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112869 · Cited by 693
Prospects for the Use of Antioxidant Therapies
Maxwell, S. R. J. (1995) · Drugs · doi:10.2165/00003495-199549030-00003 · Cited by 664
Biologically active metal-independent superoxide dismutase mimics
Mitchell, J. B., Samuni, A., Krishna, M. C., DeGraff, W. G., Ahn, M. S., Samuni, U., & Russo, A. (1990) · Biochemistry · doi:10.1021/bi00463a024 · Cited by 428
Cited by
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Kojda, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00169-8 · Cited by 768
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
Gilbert, J. S., Ryan, M. J., LaMarca, B. B., Sedeek, M., Murphy, S. R., & Granger, J. P. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01113.2007 · Cited by 558
The chemistry and biology of nitroxide compounds
Soule, B. P., Hyodo, F., Matsumoto, K.-I., Simone, N. L., Cook, J. A., Krishna, M. C., & Mitchell, J. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.030 · Cited by 519
Renal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
Self-citationOxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Wilcox, C. S. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00250.2005 · Cited by 481
Self-citationEffects of tempol and redox-cycling nitroxides in models of oxidative stress
Wilcox, C. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.003 · Cited by 465
Self-citationAntihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats
Duarte, J., Pérez‐Palencia, R., Vargas, F., Angeles Ocete, M., Pérez‐Vizcaino, F., Zarzuelo, A., & Tamargo, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704064 · Cited by 464
Oxidative Stress and Hypertension
Harrison, D. G., & Gongora, M. C. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.02.015 · Cited by 445
Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension
Vaziri, N. D., & Rodríguez-Iturbe, B. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0283 · Cited by 442
Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438
Granger, J. P., Alexander, B. T., Llinas, M. T., Bennett, W. A., & Khalil, R. A. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.718 · Cited by 401
Induction of Oxidative Stress by Glutathione Depletion Causes Severe Hypertension in Normal Rats
Vaziri, N. D., Wang, X. Q., Oveisi, F., & Rad, B. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.142 · Cited by 400
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Wilcox, C. S., & Pearlman, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000240 · Cited by 377
Self-citationChabrashvili, T., Tojo, A., Onozato, M. L., Kitiyakara, C., Quinn, M. T., Fujita, T., Welch, W. J., & Wilcox, C. S. (2002) · Hypertension · doi:10.1161/hy0202.103264 · Cited by 377
Self-citationSchnackenberg, C. G., & Wilcox, C. S. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.424 · Cited by 375
Self-citationZalba, G., Beaumont, F. J., José, G. S., Fortuño, A., Fortuño, M. A., Etayo, J. C., & Díez, J. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1055 · Cited by 369
Pathophysiology of Hypertension: The Mosaic Theory and Beyond
Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021) · Circulation Research · doi:10.1161/circresaha.121.318082 · Cited by 365
Self-citationRole of Angiotensin and Oxidative Stress in Essential Hypertension
Romero, J. C., & Reckelhoff, J. F. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.943 · Cited by 358
Reactive oxygen species: Roles in blood pressure and kidney function
Wilcox, C. S. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0041-2 · Cited by 341
Self-citationOxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency
Vaziri, N. D., Dicus, M., Ho, N. D., Boroujerdi-Rad, L., & Sindhu, R. K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00702.x · Cited by 335
Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy
Heyman, S. N., Rosen, S., Khamaisi, M., Idée, J.-M., & Rosenberger, C. (2010) · Investigative Radiology · doi:10.1097/rli.0b013e3181d2eed8 · Cited by 333
Li, L., Fink, G. D., Watts, S. W., Northcott, C. A., Galligan, J. J., Pagano, P. J., & Chen, A. F. (2003) · Circulation · doi:10.1161/01.cir.0000051459.74466.46 · Cited by 317
Kishi, T., Hirooka, Y., Kimura, Y., Ito, K., Shimokawa, H., & Takeshita, A. (2004) · Circulation · doi:10.1161/01.cir.0000128695.49900.12 · Cited by 306
Production and Actions of Superoxide in the Renal Medulla
Zou, A.-P., Li, N., & Cowley, A. W. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.547 · Cited by 295
Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis.
Khan, S. R. (2014) · PubMed · doi:10.3978/j.issn.2223-4683.2014.06.04 · Cited by 288
Nitric oxide, oxidative stress, and progression of chronic renal failure
Modlinger, P. S., Wilcox, C. S., & Aslam, S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.04.007 · Cited by 283
Self-citationSomers, M. J., Mavromatis, K., Galis, Z. S., & Harrison, D. G. (2000) · Circulation · doi:10.1161/01.cir.101.14.1722 · Cited by 279
Rodríguez-Iturbe, B., Vaziri, N. D., Herrera-Acosta, J., & Johnson, R. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00269.2003 · Cited by 277
Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease
O’Donnell, V. B., & Freeman, B. A. (2001) · Circulation Research · doi:10.1161/01.res.88.1.12 · Cited by 257
Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling
Pu, Q., Neves, M. F., Virdis, A., Touyz, R. M., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000078357.92682.ec · Cited by 255
Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension
Vaziri, N. D. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200401000-00013 · Cited by 253
Liberman, M., Bassi, E., Martinatti, M. K., Lario, F. C., Wosniak, J., Pomerantzeff, P. M. A., & Laurindo, F. R. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.156745 · Cited by 225
Role of Extracellular Superoxide Dismutase in Hypertension
Gongora, M. C., Qin, Z., Laude, K., Kim, H. W., McCann, L., Folz, J. R., Dikalov, S., Fukai, T., & Harrison, D. G. (2006) · Hypertension · doi:10.1161/01.hyp.0000235682.47673.ab · Cited by 204
A Mouse Model of Angiotensin II Slow Pressor Response: Role of Oxidative Stress
Kawada, N., Imai, E., Karber, A., Welch, W. J., & Wilcox, C. S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000035087.11758.ed · Cited by 195
Self-citationDikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., & Griendling, K. K. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00242.2010 · Cited by 179
Ferulic Acid Improves Cardiovascular and Kidney Structure and Function in Hypertensive Rats
Alam, M. A., Sernia, C., & Brown, L. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31827cb600 · Cited by 152
Manso, M. A., Miguel, M., Even, J., Hernández, R., Aleixandre, A., & López-Fandiño, R. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2007.12.049 · Cited by 133
Jaimes, E. A., Sweeney, C., & Raij, L. (2001) · Hypertension · doi:10.1161/hyp.38.4.877 · Cited by 112
Sullivan, J. C., Semprun-Prieto, L., Boesen, E. I., Pollock, D. M., & Pollock, J. S. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00429.2007 · Cited by 96
Thomas, S. R., Schulz, E., & Keaney, J. F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.012 · Cited by 37
Double-Edged Action of SOD Mimetic in Diabetic Nephropathy
Asaba, K., Tojo, A., Onozato, M. L., Goto, A., & Fujita, T. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31802b6530 · Cited by 35
Haj-Yehia, A. I., Nassar, T., Assaf, P., Nassar, H., & Änggård, E. E. (1999) · Antioxidants & Redox Signaling · doi:10.1089/ars.1999.1.2-221 · Cited by 25
Metadata
- Authors
- Schnackenberg, C. G., Welch, W. J., & Wilcox, C. S.
- Venue
- Hypertension
- Published
- 1998-07
- Volume
- 32
- Issue
- 1
- Pages
- 59-64
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2110827050
- Cited by
- 498
- References
- 35
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.